Daily Technology
·26/03/2026
Unitree Robotics' recent filing for a STAR Market IPO in Shanghai has pulled back the curtain on its operations, revealing a company with significant manufacturing leverage. While the financials point to a robust hardware business, they also suggest that the widespread industrial application of its humanoid robots is still in its nascent stages. The data presents a clear comparison between proven manufacturing capability and the still-developing market for industrial humanoids.
The most compelling data from the filing is the combination of falling prices and rising margins. The average selling price of Unitree's humanoid robots dropped from approximately $85,000 in 2023 to around $25,000 in the first nine months of 2025. Concurrently, the company-wide gross margin increased to an impressive 59.8%. This counterintuitive trend suggests a powerful cost advantage, likely stemming from the in-house development and production of core components like actuators. This manufacturing efficiency was largely built upon the foundation of its established quadruped robot business.
Despite the manufacturing success, the customer profile for Unitree's humanoids tells a different story. In the first three quarters of 2025, humanoids accounted for 51.5% of core revenue, a massive jump from 1.9% in 2023. However, the buyers are predominantly from the research and education sectors, making up 73.6% of this revenue. Commercial displays and demonstrations account for another 17.4%, leaving only 9.01% from industrial applications. This indicates that while commercially successful, the robots are not yet being deployed at scale in the factory automation environments that underpin the larger humanoid investment thesis.
Unitree's operational discipline is evident in its high sell-through rate of 95.95% for its humanoid robots, having sold 3,551 of the 3,701 units produced in the first nine months of 2025. This demonstrates efficient production management and an absence of excess inventory. However, this metric primarily reflects current demand matching production capacity; it does not definitively answer how deep the market is or whether demand will persist as the company uses its IPO proceeds to significantly expand manufacturing capabilities.
The company's strategic direction is clear. The IPO funds are earmarked for further research, new product development, and manufacturing expansion. This coincides with a rapid geographic shift in its revenue base, with mainland China now accounting for 60.8% of revenue, up from less than half in previous years. This pivot may reflect stronger domestic demand and a strategic focus on the local market.
In conclusion, Unitree's IPO filing makes a strong case for the company as a mature hardware manufacturer capable of reducing costs while scaling production. The numbers validate its operational strength. However, they also temper expectations for the immediate industrial humanoid revolution. The current revenue is driven by institutional and research adoption, not widespread factory deployment. The filing showcases a company that has mastered the hardware game, but the broader market for industrial humanoids is still playing the opening innings.









